Viking Therapeutics Commercial Paper Liability (Quarterly) Analysis

Viking Therapeutics, Inc. (VKTX)

32.90 -0.22 (-0.66%) USD | NASDAQ | Feb 26, 11:28

View Commercial Paper Liability (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Pfizer Inc.	Upgrade
Amgen, Inc.	--
Hims & Hers Health, Inc.	--
Regeneron Pharmaceuticals, Inc.	--